Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Case Reports in Oncological Medicine|May 30, 2018
An Extremely Rapid Case of Pneumonitis with the Use of Nivolumab for Pancreatic AdenocarcinomaRubens Barros Costa, Al Benson, Vahid Yaghmai, et al.Oncotarget|April 23, 2016
The challenge of developmental therapeutics for adrenocortical carcinomaRicardo Costa, Benedito A Carneiro, Fabio Tavora, et al.Drug Design, Development and Therapy|March 26, 2016
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectivesRicardo Costa, Benedito A Carneiro, Sunandana Chandra, et al.Oncotarget|May 19, 2018
Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancerRubens Barros Costa, Ricardo L B Costa, Sarah M Talamantes, et al.Journal of the American Academy of Dermatology|January 9, 2018
Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapyMaria Estela Martinez-Escala, Alba L Posligua, Heather Wickless, et al.Leukemia & Lymphoma|August 2, 2021
A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomasWilliam B Pearse, Adam M Petrich, Leo I Gordon, et al.Leukemia & Lymphoma|June 22, 2019
Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit statusAmir Behdad, Craig S Boddy, Angela J Fought, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2020
Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell LymphomaLeo I Gordon, Jason B Kaplan, Rakesh Popat, et al.Oncotarget|January 26, 2023
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)Leo I Gordon, Reem Karmali, Jason B Kaplan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2017
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete RemissionDaniel J Landsburg, Marissa K Falkiewicz, Joseph Maly, et al.Pageof 3